|
US3687808A
(en)
|
1969-08-14 |
1972-08-29 |
Univ Leland Stanford Junior |
Synthetic polynucleotides
|
|
US5585362A
(en)
|
1989-08-22 |
1996-12-17 |
The Regents Of The University Of Michigan |
Adenovirus vectors for gene therapy
|
|
US5350674A
(en)
|
1992-09-04 |
1994-09-27 |
Becton, Dickinson And Company |
Intrinsic factor - horse peroxidase conjugates and a method for increasing the stability thereof
|
|
US6156501A
(en)
|
1993-10-26 |
2000-12-05 |
Affymetrix, Inc. |
Arrays of modified nucleic acid probes and methods of use
|
|
FR2722506B1
(fr)
|
1994-07-13 |
1996-08-14 |
Rhone Poulenc Rorer Sa |
Composition contenant des acides nucleiques, preparation et utilisations
|
|
ES2192672T3
(es)
|
1996-11-18 |
2003-10-16 |
Takeshi Imanishi |
Nuevos analogos de nucleotidos.
|
|
JP3756313B2
(ja)
|
1997-03-07 |
2006-03-15 |
武 今西 |
新規ビシクロヌクレオシド及びオリゴヌクレオチド類縁体
|
|
US6143877A
(en)
|
1997-04-30 |
2000-11-07 |
Epoch Pharmaceuticals, Inc. |
Oligonucleotides including pyrazolo[3,4-D]pyrimidine bases, bound in double stranded nucleic acids
|
|
AU9063398A
(en)
|
1997-09-12 |
1999-04-05 |
Exiqon A/S |
Oligonucleotide analogues
|
|
US6127121A
(en)
|
1998-04-03 |
2000-10-03 |
Epoch Pharmaceuticals, Inc. |
Oligonucleotides containing pyrazolo[3,4-D]pyrimidines for hybridization and mismatch discrimination
|
|
JP4768132B2
(ja)
|
1999-03-24 |
2011-09-07 |
エクシコン エ／エス |
［２．２．１］ビシクロヌクレオシドの改良された製法
|
|
EP1178999B1
(en)
|
1999-05-04 |
2007-03-14 |
Santaris Pharma A/S |
L-ribo-lna analogues
|
|
US6287778B1
(en)
|
1999-10-19 |
2001-09-11 |
Affymetrix, Inc. |
Allele detection using primer extension with sequence-coded identity tags
|
|
US6660845B1
(en)
|
1999-11-23 |
2003-12-09 |
Epoch Biosciences, Inc. |
Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof
|
|
US20090247613A1
(en)
|
2002-02-20 |
2009-10-01 |
Sirna Therapeutics, Inc. |
RNA INTERFERENCE MEDIATED INHIBITION OF B-CELL CLL/LYMPHOMA-2 (BCL2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
|
US8017737B2
(en)
|
2002-11-19 |
2011-09-13 |
Hasan Kulaksiz |
Diagnostic methods for diseases by screening for hepcidin in human or animal tissues, blood or body fluids; monoclonal antibodies specific to human hepcidin and associated uses therefor
|
|
US20070270360A1
(en)
|
2003-04-15 |
2007-11-22 |
Sirna Therapeutics, Inc. |
Rna Interference Mediated Inhibition of Severe Acute Respiratory Syndrome (Sars) Gene Expression Using Short Interfering Nucleic Acid
|
|
CA2538169A1
(en)
|
2003-09-09 |
2005-03-17 |
Albert Einstein College Of Medicine Of Yeshiva University |
Transition state analog inhibitors of ricin a-chain
|
|
US20080293053A1
(en)
|
2006-12-28 |
2008-11-27 |
The Regents Of The University Of Michigan |
shRNA Materials and Methods of Using Same for Inhibition of DKK-1
|
|
US20090123501A1
(en)
|
2007-05-17 |
2009-05-14 |
Baylor College Of Medicine |
Inhibition of the sh2-domain containing protein tyr-phosphatase, shp-1, to enhance vaccines
|
|
JP2011518116A
(ja)
|
2008-02-21 |
2011-06-23 |
ユニバーシティ オブ ケンタッキー リサーチ ファウンデーション |
トール様受容体３拮抗薬としての超小型ｒｎａ
|
|
WO2009126933A2
(en)
|
2008-04-11 |
2009-10-15 |
Alnylam Pharmaceuticals, Inc. |
Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components
|
|
EP2297323A1
(en)
|
2008-05-21 |
2011-03-23 |
Hartmann, Gunther |
5' triphosphate oligonucleotide with blunt end and uses thereof
|
|
EP2318528A1
(en)
|
2008-07-24 |
2011-05-11 |
Rxi Pharmaceuticals Corporation |
Rnai constructs and uses therof
|
|
US8283460B2
(en)
|
2008-10-15 |
2012-10-09 |
Somagenics, Inc. |
Short hairpin RNAs for inhibition of gene expression
|
|
WO2010111891A1
(zh)
|
2009-04-03 |
2010-10-07 |
北京大学 |
修饰的寡聚核酸分子及其制备方法和应用
|
|
EP2508530A1
(en)
|
2011-03-28 |
2012-10-10 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
Purification of triphosphorylated oligonucleotides using capture tags
|
|
JP2015502365A
(ja)
|
2011-12-12 |
2015-01-22 |
オンコイミューニン，インコーポレイティド |
オリゴヌクレオチドのイン−ビボ送達
|
|
US10947543B2
(en)
*
|
2013-03-13 |
2021-03-16 |
Yale University |
Interferon production using short RNA duplexes
|
|
RS59500B1
(sr)
*
|
2013-05-18 |
2019-12-31 |
Aduro Biotech Inc |
Sastavi i metode za aktiviranje signaliziranja koje je zavisno od „stimulatora gena za interferon“
|
|
US10392444B2
(en)
|
2014-08-08 |
2019-08-27 |
Oncoquest, Inc. |
Tumor antigen specific antibodies and TLR3 stimulation to enhance the performance of checkpoint interference therapy of cancer
|
|
CA3089875A1
(en)
*
|
2016-02-15 |
2017-08-24 |
Trizell Ltd. |
Improved interferon therapy
|
|
WO2017173427A1
(en)
|
2016-04-01 |
2017-10-05 |
Vycellix Inc |
Novel rna construct and methods of use thereof for enhancing the therapeutic effects of cytotoxic cells and stem cells
|
|
MX2019001920A
(es)
*
|
2016-08-19 |
2019-07-01 |
Curevac Ag |
Arn la terapia contra el cancer.
|
|
US11382966B2
(en)
*
|
2017-03-24 |
2022-07-12 |
Rigontec Gmbh |
Method for designing RIG-I ligands
|
|
US10710272B2
(en)
|
2017-12-14 |
2020-07-14 |
United Technologies Corporation |
Hybrid material airflow impression molds
|
|
US10736957B2
(en)
|
2017-12-19 |
2020-08-11 |
President And Fellows Of Harvard College |
Enhanced immunogenicity of mRNA with co-encoded adjuvant sequences
|
|
EP3727146A4
(en)
|
2017-12-19 |
2021-10-06 |
Blaze Bioscience, Inc. |
TUMOR HOMING AND CELL-PENETANT PEPTIDE IMMUNO-ONCOLOGY AGENT COMPLEX AND METHOD OF USE
|
|
TW201930591A
(zh)
*
|
2018-01-08 |
2019-08-01 |
瑞士商諾華公司 |
用於與嵌合抗原受體療法併用之免疫增強rna
|
|
US11499157B2
(en)
*
|
2018-01-17 |
2022-11-15 |
Nanyang Technological University |
Immunomodulatory small hairpin RNA molecules
|
|
WO2019204743A1
(en)
|
2018-04-19 |
2019-10-24 |
Checkmate Pharmaceuticals, Inc. |
Synthetic rig-i-like receptor agonists
|